“As a 16-year veteran of medicine and board certified gastroenterologist, I see firsthand the discomfort and interference that IBS causes patients in their daily lives,” said Dr. Kenneth Brown, co-founder of Atrantíl. “Following eight years of formulation, scientific testing and development, we’ve worked hard to create Atrantíl, a unique supplement that can help alleviate bloating, abdominal discomfort and constipation where symptoms actually start—in the small bowel—without the use of harsh pharmaceuticals. For the 7-20% of the population experiencing IBS around the world this is a major breakthrough that can help them finally feel relief.”
Participants of the study ranged in age from 23-57, were diagnosed with IBS-C at least six months prior to enrollment, and had a history of uncontrolled symptoms of constipation and bloating. The study provided participants with both Atrantíl and placebos to effectively measure improved scores of IBS symptoms related to bloating, abdominal discomfort and constipation. Those who took Atrantíl showed 70% greater improvement than those that were given placebos. Participants reported no adverse events during the 2-week period.
Atrantíl is a scientifically crafted nutraceutical, made up of botanical extracts, including Quebracho, Conker Tree and Mentha balsamea Willd. These ingredients were specifically designed to work in synergy in the small bowel in order to create a sterile environment and alleviate bloating, abdominal discomfort and constipation. Available without a prescription, Atrantíl is free of milk, eggs, peanuts, soy and shellfish, and touts a patent-pending combination of certified gluten-free, vegan and non-GMO ingredients and botanical extracts.